Silfurberg

Silfurberg is an international venture capital firm based in Reykjavík, Iceland. It primarily focuses on providing early-stage capital to companies operating within the healthcare, biotechnology, and broader life sciences sectors. The firm employs a strategic investment approach, identifying nascent opportunities with significant potential for advancement and impact in these specialized scientific fields.

The firm was established in 2002 by co-founders Friðrik Steinn Kristjánsson and Ingibjörg Jónsdóttir. Their combined insight recognized an emerging need for dedicated early-stage investment within the Icelandic and international life sciences landscape, leading to the creation of a specialized vehicle to support and scale innovative ventures from their foundational stages.

Silfurberg's clientele comprises early-stage companies and entrepreneurs actively developing new technologies and solutions in health, biotech, and life sciences. The firm's overarching vision is to foster innovation by identifying and backing promising ventures, thereby contributing to the evolution of critical scientific and medical advancements. They aim to be a key partner in translating early scientific breakthroughs into impactful commercial realities.